Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer

ClinicalTrials.gov ID: NCT02111577

Public ClinicalTrials.gov record NCT02111577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy

Study identification

NCT ID
NCT02111577
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
SOTIO a.s.
Industry
Enrollment
1,182 participants

Conditions and interventions

Interventions

  • DCVAC/PCa Biological
  • Placebo Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2014
Primary completion
Jan 27, 2020
Completion
Jan 27, 2020
Last update posted
Apr 5, 2021

2014 – 2020

United States locations

U.S. sites
58
U.S. states
28
U.S. cities
55
Facility City State ZIP Site status
University of South Alabama Mitchell Cancer Institute Mobile Alabama 36604
Ironwood Cancer & Research Centers Chandler Arizona 85224
Mayo Clinic Scottsdale Arizona 85259-5499
Compassionate Care Research Group, Inc. Corona California 92879
California Cancer Associates for Research and Excellence Encinitas California 92024
Compassionate Care Research Group, Inc. Fountain Valley California 92708
St. Joseph Heritage Healthcare Fullerton California 92835
Hao Wei Zhang, MD, LLC Los Angeles California 90033
Desert Hematology Oncology Medical Group Rancho Mirage California 92270
Compassionate Care Research Group, Inc. Riverside California 92501
Sharp Clinical Oncology Research San Diego California 92123
Oncology Institute of Hope and Innovation Whittier California 90603
Rocky Mountain Cancer Centers Aurora Colorado 80012
University of Colorado Aurora Colorado 80045
Yale Cancer Center New Haven Connecticut 06519
Eastern CT Hematology and Oncololgy Associates Norwich Connecticut 06360
Medstar Georgetown University Hospital Washington D.C. District of Columbia 20007
Univ. of Miami, Sylvester Comprehensive Cancer Center Miami Florida 33136
Winship Cancer Institute of Emory University Atlanta Georgia 30322
Saint Luke's Cancer Institute Kansas City Kansas 64111
University of Kansas Cancer Center & Medical Pavilion Westwood Kansas 66205
Tulane University New Orleans Louisiana 70112
University of Maryland Greenebaum Cancer Center Baltimore Maryland 21201
Associates In Oncology/Hematology,P.C Rockville Maryland 20850
Dana-Farber Cancer Institute Boston Massachusetts 02115
Umass Memorial Medical Center Worcester Massachusetts 01655
Henry Ford Health System Detroit Michigan 48202
Karmanos Cancer Center Detroit Michigan 48202
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404
GU Research Network Omaha Nebraska 68130
Nebraska Cancer Specialists Omaha Nebraska 68130
Comprehensive Cancer Research Centers of Nevada Henderson Nevada 89052
New Jersey Hematology Oncology Associates Brick New Jersey 08724
Premier Urology Associates, LLC / AdvanceMed Research Lawrenceville New Jersey 08648
Cancer Institute of New Jersey New Brunswick New Jersey 08901
Mount Sinai Medical Center New York New York 10029
SUNY Upstate Medical University Syracuse New York 13210
Montefiore Medical Center The Bronx New York 10467
UC Health University of Cincinnati Cincinnati Ohio 45267
Oregon Health & Science University Portland Oregon 97239
Northwest Cancer Specialists, P.C. Tualatin Oregon 97062
Urologic Consultants of Southeastern Pennsylvania Bala-Cynwyd Pennsylvania 19004
Cancer Care Associates St. Luke's University and Health Network Easton Pennsylvania 18045
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
UPMC Cancer Center Pittsburgh Pennsylvania 15232
Carolina Urologic Research Center Myrtle Beach South Carolina 29572
Associates in Oncology & Hematology Chattanooga Tennessee 37421
Arlington Cancer Center Arlington Texas 76012
UT Health, Internal Medicine, Division of Oncology Houston Texas 77030
Texas Health Physicians Group Plano Texas 75093
Cancer Care Network of South Texas San Antonio Texas 78217
Tyler Hematology Oncology Tyler Texas 75701
Utah Cancer Specialists Salt Lake City Utah 84106
Fort Belvoir Community Hospital Fort Belvoir Virginia 22060
Virginia Oncology Associates Norfolk Virginia 23502
Virginia Mason Medical Center Seattle Washington 98012
Northwest Medical Specialties, PLLC Tacoma Washington 98405
West Virginia University Mary Babb Randolph Cancer Center Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02111577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 5, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02111577 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →